Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5887_Библиотеки_им_академика_М_И_Перельмана
.pdf
66
https://t.me/medicina_free
cells activated by microglia-conditioned media due to skimmianine treatment indicating its neuroprotective potential (Ogunrinade et al, 2023).
NeuroPhytomedicine
4.2.15 solAsoDine
Solasodine (16) is an anti-oxidant glycoalkaloid present in Solanum species. In I/Rinjury rat model, solasodine showed a marked decrease in neuronal damage with a
signicant increase in SOD, CAT, GSH and total thiols (Sharma et al, 2014). It also
reduced glutamate-induced excitotoxicity of PC12 cells. However, the alkaloid did
not prevent cell death due to glucose deprivation and mitochondrial damage (GarcíaPupo et al, 2016).
4.2.16 tomAtine AnD tomAtiDine
Tomatine (17) and tomatidine (18) are the steroidal alkaloids present in tomatoes.
Tomatidine has shown neuroprotective activity by alleviating injury oxygen-glucose
deprivation followed by reperfusion (OGD/R) in mice cortical neurons and N2a cells.
It induced autophagy by increasing the number of lysosomes rather than through
autophagosome formation. The proteolytic activity and levels of Cathepsin B and
D were raised in the cells. It also increased the expression and nuclear translocation
of transcription factor EB (TFEB) (Ahsan et al, 2020). In another study, tomatine
and tomatidine reduced glutamate-induced toxicity on SH-SY5Y cells and rendered
neuroprotection. The mitochondrial membrane potential also remained unaltered in
AGS, Caco-2 and SH-SY5Y cells after the treatment. Further, the ROS levels were
decreased in SH-SY5Y cells (Taveira et al, 2014). Tomatine has shown a neuroprotective effect against H2O2 insult on SH-SY5Y cells. It raised anti-oxidant enzyme
levels and BNDF expression in the cells along with the downregulation of Bax and
activity of caspase-3 and 9 (Huang et al, 2014).
4.2.17 trigonelline
Trigonelline (19) is a pyridine alkaloid obtained from fenugreek seed, coffee, garden peas, etc. Trigonelline has a neuroprotective effect against ischemia induced by
MCAO in rats. It has shown a reduction in the elevated nitrite and MDA levels relieving oxidative stress. It inhibited reduced GSH-mediated myeloperoxidase expression in the cortex of the brain (Pravalika et al, 2019). In the 6-OHDA-induced PD
model, trigonelline prevented neuronal death and apoptosis in substantia nigra pars
compacta and restored MDA level (Mirzaie et al, 2016). In the chronic d-galactose
model, trigonelline displayed a marked reduction in advanced glycation end product
(AGEs) levels and oxidative stress along with a signicant reduction in AChE levels
leading to neuroprotection (Chowdhury et al, 2018). In OGD/R-induced hippocampal neurons, trigonelline treatment suppressed caspase-3 activity and bax expression
along with the induction of bcl-2 expression. It induced PI3K/Akt signalling leading
to neuroprotection in hippocampal neuronal injury (Qiu et al, 2020). Trigonelline
also reversed the LPS-induced behavioural and memory decits and restored levels of anti-oxidant enzymes and AChE in the hippocampus and cortex. The levels
67The Neuroprotective Effect of Alkaloids and Synthetic Derivatives
https://t.me/medicina_free
of TNF-α and IL-6 were alleviated along with the upregulation of BDNF, indicat-
ing the promising neuroprotective property (Chowdhury et al, 2018). Similar results
were found in another study where trigonelline ameliorated LPS-induced hippocampal oxidative stress and neuroinammation and reduced expression of NF-κβ, tolllike receptor 4 (TLR4), and TNF-α (Khalili et al, 2018). Trigonelline was also found
to be effective against diabetic neuropathy with the restoration of the impaired motor
and sensory nerve conduction and downregulation of glucagon-like peptide 1 protein
and phosphorylated p38 MAPK protein in plasma and sciatic nerve, respectively
(Zhou and Zhou, 2012). In Aβ
-induced toxicity in rats, trigonelline has shown
1–40
improved mitochondrial membrane potential and lowered hippocampal MDA, protein carbonyl and LDH levels. It also signicantly ameliorated hippocampal levels
of TNF-α, IL-6, glial brillary acidic protein (GFAP), S100b and Cox2 (Fahanik-
Babaei et al, 2019).
4.2.18 vincAmine
Vincamine (20) is an indole-containing monoterpenoid alkaloid present in Vinca
minor. Vincamine has displayed neuroprotection against Aβ
and reduced apoptosis in PC12 cells. It activates PI3K/Akt pathway and upregulates SOD (Han et al, 2017). In another study, vincamine resulted in 50% clearance of brain iron content, reducing oxidative stress (Fayed, 2010). Vindeburnol,
a vincamine derivative, reduced the astrocyte activation and demyelination in the
cerebellum of C57BL/6 mice treated immunised with myelin oligodendrocyte glycoprotein (MOG
). Locus coeruleus also appeared to have lower astrocyte acti-
35-55
vation along with attenuated tyrosine hydroxylase-positive neuronal hypertrophy
(Polak et al, 2012).
The neuroprotective mode of action of other alkaloids is presented in Table 4.2.
induced toxicity
25–35
4.3 SYNTHETIC AND SEMI-SYNTHETIC DERIVATIVES
OF NEUROPROTECTIVE ALKALOIDS
The synthetic and semi-synthetic derivatives of alkaloids along with the neuroprotective mechanism, are presented in Table 4.3.
4.4 FUTURE PROSPECTS
Alkaloids are indeed an interesting class of plant secondary metabolites synthesised
from amino acids with a wide spectrum of medicinal properties. Being widely distributed in the plant kingdom, they are well used in traditional medicine in the form
of extracts. The advancement in modern technology has been helpful in the isolation
of these alkaloids in their pure form. The alkaloids have shown various CNS activities with neuroprotection as one of the crucial properties. Neurodegeneration is an
unavoidable phenomenon related to ageing, which involves dysfunctional cellular
machinery leading the cell death. The plausible cause would be membrane damage,
DNA damage, dysfunctional mitochondria and hampered cellular pathways such as
axonal transport and protein degradation machinery. Neuroprotection is important
TABLE 4.2
https://t.me/medicina_free
Alkaloids along with Their Neuroprotective Mechanism.
Alkaloid Dose(s) Model Mode of Action(s) References
Aloperine 25, 50, and
100 mg/l
OGD/R
↑ Mitochondrial membrane potential,
inhibited intracellular-free Ca+2, ↓ ROS,
↑ SOD, CAT and GP
(Ma et al,
2015)
68
Capsaicin 10 mg/kg Cold water stress in rats
Coptisine
20 and 30 mg/kg Male Sprague–Dawley rats
0.2 and 2.0 mg/kg Hypoxic-ischemic neonatal brain
injury model
3–30 μM/L
0.1–40 μM
Hypoxia-reoxygenation-induced
primary rat hippocampal neuron
tert-butyl hydroperoxide-induced
apoptosis
↑ Synapsin I and PSD93 levels prevent tau
hyperphosphorylation through the reversal
of suppression of protein phosphatase 2A
↑ Amyloidogenic APP processing,
↑ membrane-bound APP
↓ Infarction volume and prevent apoptosis
↑ Akt phosphorylation, ↓ apoptosis
↓ Apoptosis, ↓ thioredoxin-interacting
protein (TXNIP) gene, apoptosis ↓
signal-regulating kinase
(Jiang et al,
2013)
(Pákáski
et al, 2009)
(Khatibi
et al, 2011)
(Guo et al,
2008)
(Friedemann
et al, 2015)
NeuroPhytomedicine
(Continued)
TABLE 4.2
https://t.me/medicina_free
(Continued)
Alkaloids along with Their Neuroprotective Mechanism.
Alkaloid Dose(s) Model Mode of Action(s) References
Cryptolepine
2.5–20 μM IL-1β-stimulated SK-N-SH
neuroblastoma
LPS-induced neuroinammation
in rat microglia
↓ Production of IL-6, PGE2 and TNFα,
inhibition of NF-κβp65 nuclear
translocation
↓ NF-KappaB inhibited p38 and
MAPKAPK2 phosphorylation in the
microglia
(Olajide et al,
2013a)
(Olajide et al,
2013b)
The Neuroprotective Effect of Alkaloids and Synthetic Derivatives
Cystine
Isocorynoxeine
0–400 μM
100 μM
NMDA-injured cortical neurons
Glutamate-induced HT22 cells
↓ GluN2B-containing NMDA receptors and
modulate Bcl-2
↓ Cell death
(Li et al,
2013)
(Qi et al,
2015)
(Continued)
69
TABLE 4.2
https://t.me/medicina_free
(Continued)
Alkaloids along with Their Neuroprotective Mechanism.
Alkaloid Dose(s) Model Mode of Action(s) References
Oxysophocarpine
1, 2 and 5 μM/L
OGD/R-insulted neonatal rat
↓ Neuronal death, ↓ morphologic
impairment
(Zhu et al,
2014)
70
Racemoside A
10 μM Aβ
-induced SH-SY5Y cell
25–35
damage
↓ Cell death
(Liu et al,
2013)
NeuroPhytomedicine
TABLE 4.3
https://t.me/medicina_free
Synthetic and Semi-Synthetic Derivatives of Neuroprotective Alkaloids.
Alkaloidal Derivative Dose(s) Model(s) Mode of Action(s) References
N-(3,4-dimethoxyphenethyl)-2-((1,3,7-trimethyl-2,6-dioxo-
2,3,6,7-tetrahydro-1H-purin-8-yl)thio)acetamide
100 μM
6-OHDA-induced toxicity in
SH-SY5Y cell
↑ Cell viability
(Kasabova-
Angelova et al,
2020)
The Neuroprotective Effect of Alkaloids and Synthetic Derivatives
N′-(2-hydroxybenzylidene)-3-(1,3,7-trimethyl-2,6-dioxo-
2,3,6,7-tetrahydro-1H-purin-8-ylthio)propanehydrazide
100 μM
Rat brain synaptosomes and
mitochondria
↑ Cell viability, ↑ GSH, ↓ MDA, ↓
oxidative stress
(Kondeva-
Burdina et al,
2022)
(Continued)
71
TABLE 4.3
https://t.me/medicina_free
(Continued)
Synthetic and Semi-Synthetic Derivatives of Neuroprotective Alkaloids.
Alkaloidal Derivative Dose(s) Model(s) Mode of Action(s) References
Vinpocetine
Cis-apovincaminic acid
1–50 μM
1–50 μM
– Microglial cell M2 in OGD
1–100 μM
3 mg/kg Permanent MCAO model
10 mg/kg NMDA-induced
Glutamate excitotoxicity on
primary cortical neurons
Primary cortical neurons
ischemic model
OGD-induced damage BV2 cells
Sodium azide-induced hypoxia
in chick embryo cerebral
hemisphere neuronal culture
Primary cortical cell
neurodegeneration in rats
Inhibition of voltage-dependent Na+
channel and interaction with glutamate
receptors
↓ Glutamate excitotoxicity, reduction of
inner mitochondrial membrane potential
Inhibits phosphodiesterase (PDE) 1-B (Zang et al,
↓ Neuronal death
↓ Infraction volume
↓ LDL level, ↓ viability
↓ Transient NMDAR, transient
N-methyl-D-aspartate, ↓ veratridineinduced excitotoxicity
Alleviate entorhinal NMDA lesions and
microglia activation
(Bönöczk et al,
2000; Tárnok
et al, 2008)
100
2021)
(Krieglstein and
Rischke, 1991)
(Dézsi et al,
2002)
(Nyakas et al,
2009)
72
NeuroPhytomedicine
The Neuroprotective Effect of Alkaloids and Synthetic Derivatives
https://t.me/medicina_free
73
for the prolonged survival of neuronal cells, especially in the case of neurodegenerative diseases. Alkaloids displayed neuroprotection through various routes and mechanisms, viz. minimising DNA and cellular damage by neutralising ROS, preventing
the release of pro-inammatory mediators, activating anti-apoptotic pathways and
decreasing the expression of inammatory markers. The bioavailability and BBB
permeability of the alkaloids are still a major concern. The semi-synthetic and synthetic derivatives with suitable physicochemical properties for bioavailability could
be a plausible avenue for the development of new lead molecules. However, there
is still a need for the development of such derivatives, with a few available to date.
REFERENCES
Abdel-Salam, Omar M. E., Amany Ameen Sleem, Yasser Ashry Khadrawy, and Fatma A.
Morsy. 2020. “Prevention of toluene-induced brain neurodegeneration by atropine and
neostigmine.” Journal of Basic Pharmacology and Toxicology 4 (1): 1–9.
Abdel Moneim, Ahmed E. 2015. “The neuroprotective effect of berberine in mercury-induced
neurotoxicity in rats.” Metabolic Brain Disease 30: 935–942.
Abin-Carriquiry, J. Andrés, Gustavo Costa, Jessika Urbanavicius, Bruce K. Cassels, Marco
Rebolledo-Fuentes, Susan Wonnacott, and Federico Dajas. 2008. “In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: Implications for
Parkinson’s disease.” European Journal of Pharmacology 589 (1–3): 80–84.
Adamski, Z., L. L. Blythe, L. Milella, and S. A. Bufo. 2020. “Biological activities of alkaloids:
From toxicology to pharmacology.” Toxins (Basel) 12 (4): 210. https://doi.org/10.3390/
toxins120 40210, https://www.ncbi.nlm.nih.gov/pubmed/32224853.
Ahsan, Anil, Yanrong Zheng, Shijia Ma, Mengru Liu, Ming Cao, Yue Li, Wanqing Zheng,
Xinyu Zhou, Minhang Xin, Wei-Wei Hu, Zhong Chen, and Xiangnan Zhang. 2020.
“Tomatidine protects against ischemic neuronal injury by improving lysosomal function.”
European Journal of Pharmacology 882: 173280. https://doi.org/10.1016/j.ejphar.2020.
173280. https://www.sciencedirect.com/science/article/pii/S0014299920303721.
Alexander, Kathleen S., Hui-Qiu Wu, Robert Schwarcz, and John P. Bruno. 2012. “Acute
elevations of brain kynurenic acid impair cognitive exibility: Normalization by the
alpha7 positive modulator galantamine.” Psychopharmacology 220: 627–637.
Bagga, Puneet, Anup N. Chugani, and Anant B. Patel. 2016. “Neuroprotective effects of caf-
feine in MPTP model of Parkinson’s disease: A 13C NMR study.” Neurochemistry
International 92: 25–34.
Bhat, Abid, Vanessa Tan, Benjamin Heng, Sharron Chow, Salundi Basappa, Musthafa M.
Essa, Saravana B. Chidambaram, and Gilles J. Guillemin. 2021. “Papaverine, a phosphodiesterase 10a inhibitor, ameliorates quinolinic acid-induced synaptotoxicity in
human cortical neurons.” Neurotoxicity Research 39 (4): 1238–1250.
Biradar, S. M., Hanumanthachar Joshi, and K. C. Tarak. 2013. “Cerebroprotective effect of
isolated harmine alkaloids extracts of seeds of Peganum harmala L. on sodium nitriteinduced hypoxia and ethanol-induced neurodegeneration in young mice.” Pakistan
Journal of Biological Sciences: PJBS 16 (23): 1687–1697.
Bönöczk, Péter, Balázs Gulyás, Vera Adam-Vizi, András Nemes, Egon Kárpáti, Béla Kiss,
Margit Kapás, Csaba Szántay, István Koncz, Tibor Zelles, and Adam Vas. 2000. “Role
of sodium channel inhibition in neuroprotection: Effect of vinpocetine.” Brain Research
Bulletin 53 (3): 245–254. https://doi.org/10.1016/S0361-9230(00)00354-3, https://www.
sciencedirect.com/science/article/pii/S0361923000003543.
Cai, Cui-Zan, He-Feng Zhou, Ning-Ning Yuan, Ming-Yue Wu, Simon Ming-Yuen Lee, Jiao-
Yan Ren, Huan-Xing Su, Jin-Jian Lu, Xiu-Ping Chen, and Min Li. 2019. “Natural
74
https://t.me/medicina_free
alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitinproteasome system activation.” Phytomedicine 61: 152842.
Chen, Siyuan, Nong Xiao, and Xiaoping Zhang. 2009. “Effect of combined therapy with
ephedrine and hyperbaric oxygen on neonatal hypoxic–ischemic brain injury.”
Neuroscience Letters 465 (2): 171–176.
Chen, Yifan, Gang Cheng, Rongfeng Hu, Shengqi Chen, Wenjie Lu, Song Gao, Hongmei
Xia, Bin Wang, Chaojie Sun, and Xiangjiang Nie. 2019. “A nasal temperature and pH
dual-responsive in situ gel delivery system based on microemulsion of huperzine A:
Formulation, evaluation, and in vivo pharmacokinetic study.” AAPS PharmSciTech
20: 1–12.
Chowdhury, Amrita A., Nitin B. Gawali, Vipin D. Bulani, Pankaj S. Kothavade, Snehal N. Mestry,
Padmini S. Deshpande, and Archana R. Juvekar. 2018. “In vitro antiglycating effect and in
vivo neuroprotective activity of trigonelline in d-galactose induced cognitive impairment.”
Pharmacological Reports 70 (2): 372–377. https://doi.org/10.1016/j.pharep.2017.09.006,
https://www.sciencedirect.com/science/article/pii/S1734114017301846.
Chowdhury, Amrita A., Nitin B. Gawali, Renuka Munshi, and Archana R. Juvekar. 2018.
“Trigonelline insulates against oxidative stress, proinammatory cytokines and restores
BDNF levels in lipopolysaccharide induced cognitive impairment in adult mice.”
Metabolic Brain Disease 33 (3): 681–691. https://doi.org/10.1007/s11011-017-0147-5.
Correia, Alyne Oliveira, Abílio Augusto Pimentel Cruz, Arôdo Tenório Ribeiro de Aquino,
Joanisson Rubens Gomes Diniz, Karizia Bianca Ferreira Santana, Pedro Ivo Martins
Cidade, Jaine Dantas Peixoto, Daniel Luna Lucetti, Maria Elizabeth Pereira Nobre, and
Giovany Michely Pinto da Cruz. 2015. “Neuroprotective effects of piperine, an alkaloid
from the Piper genus, on the Parkinson’s disease model in rats.” Journal of Neurology
and Therapeutics 1 (1): 1–18.
Cushnie, T. P. Tim, Benjamart Cushnie, and Andrew J. Lamb. 2014. “Alkaloids: An overview
of their antibacterial, antibiotic-enhancing and antivirulence activities.” International
Journal of Antimicrobial Agents 44 (5): 377–386. https://doi.org/10.1016/j.ijantimicag.
2014.06.0 01, https://www.sciencedirect.com/science/article/pii/S0924857914001885.
da Costa e Silva, Liana Dantas, Patrícia Pereira, Gabriela Gregory Regner, Fernanda
Brião Menezes Boaretto, Cleonice Hoffmann, Pricila Püger, Lucas Lima da Silva,
Luiza Reinhardt Steffens, Ana Moira Morás, Dinara Jaqueline Moura, and Jaqueline
Nascimento Picada. 2018. “DNA damage and oxidative stress induced by seizures
are decreased by anticonvulsant and neuroprotective effects of lobeline, a candidate
to treat alcoholism.” Metabolic Brain Disease 33 (1): 53–61. https://doi.org/10.1007/
s11011-017-0130-1.
Dang, Thu Kim, Min Hong, Vui Thi Dao, Duong Thuy Nguyen, Khanh Van Nguyen, Hai
Than h Ng uyen , Sana Ulla h, Hiep Tua n Tr an, and Sun Yeou K im. 2023. “Neuroprotect ive
effects of total alkaloids fraction of Huperzia serrata on scopolamine-induced neurodegenerative animals.” Phytotherapy Research 37 (1): 140–150.
Dang, Yalong, Yalin Mu, Kun Wang, Ke Xu, Jing Yang, Yu Zhu, and Bin Luo. 2016.
“Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.” Drug Design, Development and Therapy 10: 851–859.
https://doi.org/10.2147/DDDT.S97380, https://www.tandfonline.com/doi/abs/10.2147/
DDDT.S97380.
de Lima, Neila Maria R., Emerson de O. Ferreira, Mara Yone S. D. Fernandes, Francisco
Arnaldo V. Lima, Kelly Rose T. Neves, Marta Regina S. do Carmo, and Geanne M. de
Andrade. 2017. “Neuroinammatory response to experimental stroke is inhibited by
boldine.” Behavioural Pharmacology 28 (2): 223–237.
Debnath, Bikash, Waikhom Somraj Singh, Manik Das, Sanchari Goswami, Mahesh Kumar
Singh, Debasish Maiti, and Kuntal Manna. 2018. “Role of plant alkaloids on human
health: A review of biological activities.” Materials Today Chemistry 9: 56–72.
NeuroPhytomedicine
The Neuroprotective Effect of Alkaloids and Synthetic Derivatives
https://t.me/medicina_free
Dewick Paul, M. 2009. Medicinal Natural Products. 3rd ed. Chichester: Wiley.
Dézsi, László, Istvánné Kis-Varga, József Nagy, Zsolt Komlódi, and Egon Kárpáti. 2002.
“Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid
derivatives as potential therapeutic tools in ischemic stroke.” Acta Pharmaceutica
Hungarica 72 (2): 84–91.
Dhote, Franck, Pierre Carpentier, Laure Barbier, André Peinnequin, Valérie Baille, Fabien
Pernot, Guy Testylier, Claire Beaup, Annie Foquin, and Fréderic Dorandeu. 2012.
“Combinations of ketamine and atropine are neuroprotective and reduce neuroinammation after a toxic status epilepticus in mice.” Toxicology and Applied Pharmacology
259 (2): 195–209.
Dolanbay, Serap Nigdelioglu, Fatma Gonca Kocanci, a nd Belma Aslim. 2021. “Neuroprotect ive
effects of allocryptopine-rich alkaloid extracts against oxidative stress-induced neuronal damage.” Biomedicine & Pharmacotherapy 140: 111690.
Durairajan, Siva Sundara Kumar, Liang-Feng Liu, Jia-Hong Lu, Lei-Lei Chen, Qiuju Yuan,
Sookja K. Chung, Ling Huang, Xing-Shu Li, Jian-Dong Huang, and Min Li. 2012.
“Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in
an Alzheimer’s disease transgenic mouse model.” Neurobiology of Aging 33 (12):
2903–2919. https://doi.org/10.1016/j.neurobiolaging.2012.02.016, https://www.science
direct.com/science/article/pii/S0197458012001613.
El Madani, Mevidette A., R. M. A. Elsalam, Amina S. Attia, S. M. El-Shenawy, and Mahmoud
S. Arbid. 2016. “Neuropharmacological effects of naringenin, harmine and adenosine
on parkinsonism induced in rats.” Scholars Research Library 8 (5): 45–57.
Enye, Linus Anderson, Edem Ekpenyong Edem, Ishola Olakunle Azeez, Mary Essien Umoh,
Achonwa-Njemanze Nneoma, and Abimbola John Ajayi. 2017. “Spatial memory, motor
coordination, cerebellar and hippocampal histoarchitectural changes following atropine administration to adult mice.” International Biological and Biomedical Journal
3(3): 125–132.
Eyerman, David J, and Bryan K Yamamoto. 2005. “Lobeline attenuates methamphet-
amine-induced changes in vesicular monoamine transporter 2 immunoreactivity and
monoamine depletions in the striatum.” Journal of Pharmacology and Experimental
Therapeutics 312 (1): 160 –169.
Fahanik-Babaei, Javad, Tourandokht Baluchnejadmojarad, Farnaz Nikbakht, and Mehrdad
Roghani. 2019. “Trigonelline protects hippocampus against intracerebral Aβ (1– 40)
as a model of Alzheimer’s disease in the rat: Insights into underlying mechanisms.”
Metabolic Brain Disease 34: 191–201.
Fayed, A. H. 2010. “Brain trace element concentration of rats treated with the plant alka-
loid, vincamine.” Biological Trace Element Research 136 (3): 314–319. https://doi.
org/10.1007/s12011-009-8550 -3.
Friedemann, Thomas, Udo Schumacher, Yi Tao, Alexander Kai-Man Leung, and Sven
Schröder. 2015. “Neuroprotective activity of coptisine from Coptis chinensis (Franch).”
Evidence-Based Complementary and Alternative Medicine 2015: 827308. https://doi.
org/10.1155/2015/827308.
Fu, Min, Zhao-Hui Sun, and Huan-Cong Zuo. 2010. “Neuroprotective effect of piperine on
primarily cultured hippocampal neurons.” Biological and Pharmaceutical Bulletin
33 (4): 598–603.
García-Pupo, L., A. Zaldo-Castro, V. Exarchou, J. E. Tacoronte-Morales, L. Pieters, W.
Vanden Berghe, Y. Nuñez-Figueredo, and R. Delgado-Hernández. 2016. “In vitro neuroprotective and anti-inammatory activities of natural and semi-synthetic spirosteroid
analogues.” Molecules 21 (8). https://doi.org/10.3390/molecules21080992.
Gavilan, Javiera, Daniela Mennickent, Oscar Ramirez-Molina, Sergio Triviño, Claudia
Perez, Tiare Silva-Grecchi, Pamela A. Godoy, Jose Becerra, Luis G. Aguayo, Gustavo
Moraga-Cid, Victoria San Martin, Gonzalo E. Yevenes, Patricio A. Castro, Leonardo
75
Соседние файлы в папке Библиотека им академика М.И. Перельмана